• Exchange: NASDAQ GM
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

Akebia Therapeutics Inc

+ Add to Watchlist

AKBA:US

11.2300 USD 0.3100 2.69%

As of 17:10:00 ET on 12/24/2014.

Snapshot for Akebia Therapeutics Inc (AKBA)

Open: 11.5000 Day's Range: 11.1400 - 11.5000 Volume: 69,253
Previous Close: 11.5400 52wk Range: 8.6000 - 31.0000 1-Yr Rtn: -

Stock Chart for AKBA

No chart data available.
  • AKBA:US 11.2300
  • 1D
  • 1M
  • 1Y
11.5400
Interactive AKBA Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for AKBA

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. SPX -
Earnings Per Share (USD) (ttm) -
Est. EPS (USD) (12/2014) -6.9900
Est. PEG Ratio -
Market Cap (M USD) 228.43
Shares Outstanding (M) 20.34
30 Day Average Volume 220,922
Price/Book (mrq) 2.0065
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 02/21/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for AKBA

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for AKBA

Akebia Therapeutics, Inc. manufactures biopharmaceutical products. The Company develop and distributes novel therapeutics based on the biology of hypoxia inducible factor (HIF) for patients with kidney diseases. Akebia Therapeutics serves customers in the United States.

John P ButlerPresident/CEOJason A AmelloSenior VP/CFO/Treasurer
Brad MaroniSenior VP/Chief Medical OfficerNicole R Hadas "Nikki"VP/General Counsel
More Company Profile & Key Executives for AKBA

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil